Shopify Bloodborne Pathogens PPE Schema — OSHA 1910.1030 Nitrile Gloves, ASTM F1671 Gowns, Face Shield vs Safety Glasses, Sharps Containers, bbp_ppe.* Namespace

OSHA 1910.1030 applies to human blood and to OPIM — Other Potentially Infectious Materials — a defined list of body substances that must be treated as potentially infectious for HIV, HBV, and HCV. OPIM includes: cerebrospinal fluid (CSF), synovial fluid, pleural fluid, peritoneal fluid, pericardial fluid, and amniotic fluid — all fluids from body cavities that may contain infectious material in high concentrations. Semen and vaginal secretions — primary transmission routes for HIV. Any body fluid visibly contaminated with blood — saliva, vomit, or urine that contains visible blood becomes OPIM. Unfixed human tissue or organs (other than intact skin) — relevant for laboratory and anatomical pathology work. HIV-containing cell or tissue cultures, HIV-containing culture media, and HBV-containing material in research laboratories. Notably, sweat, tears, feces (unless visibly bloody), urine (unless visibly bloody), saliva (except in dental settings where saliva is likely contaminated with blood), sputum, nasal secretions, and vomitus are NOT OPIM under 1910.1030 unless visibly contaminated with blood. However, universal precautions remain the safest practical approach — treating all patient contact as potentially involving OPIM eliminates the need for real-time visual assessment of each body fluid encountered. Encode bbp_ppe.osha_1910_1030_use_case to differentiate clinical (all OPIM categories), emergency-response (primarily blood, CSF in trauma), laboratory (cultures and specimens), and janitorial (cleanup of spills, primarily blood and visually contaminated fluids).

Double-gloving — wearing two layers of gloves simultaneously — is not universally required by OSHA 1910.1030, but OSHA's compliance guidance and recommendations from AORN (Association of periOperative Registered Nurses) and CDC recommend double-gloving for surgical procedures with high sharps exposure. The rationale: a double-glove system reduces the interior glove perforation rate by 87% compared to single gloving in high-risk surgical procedures (orthopedic, gynecological, cardiac surgery). Even when the outer glove is perforated by a suture needle or bone fragment, the inner glove remains intact in the majority of cases, maintaining the barrier between the patient's blood and the worker's skin. Glove indicator systems: these are a subset of double-glove systems where the inner (indicator) glove is dyed a contrasting color (typically green or dark blue). When the outer white glove is perforated, the indicator dye becomes visible through the outer glove as a dark spot — alerting the wearer to change gloves without requiring cessation of the sterile field to inspect for breach. Standard double-gloving without indicator dye requires periodic manual inspection or sentinel events (perceived puncture, patient blood visible through gloves) to detect perforation. For interventional procedures and high-risk sharps handling, encode bbp_ppe.double_glove_system as 'yes' for glove sets designed for this use, and note whether an indicator dye is present in the product description.

OSHA 1910.1030(f)(1) requires employers to make HBV vaccination available to all employees who have occupational exposure to bloodborne pathogens, subject to the following conditions: timing — the vaccine series must be offered within 10 working days of the employee's initial assignment to a job with occupational exposure risk. Cost — the vaccination must be provided at no cost to the employee, at a reasonable time and place, and under the supervision of a licensed physician or other healthcare professional. Pre-screening prohibition — employers may NOT make participation in a pre-screening program (antibody titer testing) a prerequisite for receiving the vaccine. After vaccination — employers must ensure a follow-up antibody titer is offered to determine whether the employee has responded to the vaccine. Non-responders (approximately 5-10% of vaccinated individuals do not develop protective antibody titers) require follow-up evaluation including a second vaccination series and/or enhanced monitoring for exposure incidents. Declination: an employee who declines the HBV vaccination must sign an OSHA-specified declination statement, which does not prevent the employee from later receiving the vaccine if they change their mind. The declination form must be retained as part of the employee's medical record. This vaccination obligation applies to all workers with occupational exposure — healthcare, emergency medical services, clinical laboratory, mortuary science, research laboratories, and others. Post-exposure vaccination for HBV is covered under the post-exposure incident evaluation (1910.1030(f)(3)) for unvaccinated workers exposed to HBV-positive source material.

OSHA 1910.1030 requires that resuscitation equipment be available to eliminate mouth-to-mouth resuscitation when occupational exposure may occur. The specific requirements and equipment options: pocket face masks with one-way valve — a transparent dome-shaped mask that covers the mouth and nose, with a one-way valve that channels rescuer breath into the victim while preventing the victim's exhaled air (and potentially infectious saliva, blood, or emesis) from reaching the rescuer. These are the minimum standard device for CPR in BBP-regulated workplaces. Bag-valve-mask (BVM) devices — a self-inflating resuscitator bag connected to a face mask and one-way valve system. Eliminates direct breath contact entirely — the rescuer squeezes the bag to deliver ventilation without placing their mouth anywhere near the patient's face. BVM devices are the standard for professional emergency responders, first responders, and healthcare workers. These devices must be accessible at the worksite — not locked in a supply closet requiring a key. OSHA compliance officers in BBP audits look for resuscitation equipment at the point of potential use (AED stations, first aid areas, high-traffic patient care areas). Encode bbp_ppe.osha_1910_1030_use_case as 'emergency-response' for pocket masks and BVM devices, and verify that resuscitation equipment products include the one-way valve specification in product metadata — a basic face shield without a one-way valve does not meet the OSHA 1910.1030 requirement for resuscitation equipment.

OSHA 1910.1030 implements the hierarchy of controls for bloodborne pathogen protection. Engineering controls come before PPE in the hierarchy and must be used where feasible before relying on PPE. The 2001 Needlestick Safety and Prevention Act amended OSHA 1910.1030 to specifically require employers to evaluate and implement safety-engineered sharps devices (SESIP — Safety-Engineered Sharps Injury Prevention devices) where available. Needleless systems: eliminate sharps entirely for medication delivery through compatible IV systems, blunt-cannula access ports, and needleless transfer devices. Where a needle can be eliminated, it must be eliminated — PPE cannot substitute for eliminating the needle. SESIP devices: safety-engineered syringes (retractable needle sheaths that activate automatically or require one-hand engagement), surgical suture needles with blunt tips for fascial closure, safety scalpels with blade guards. Safety lancets for blood glucose testing. The engineering control mandate: employers must implement SESIP wherever FDA has cleared a device for the intended use, unless clinical effectiveness would be compromised. Employers must maintain a sharps injury log and use it to evaluate whether SESIP implementation has reduced injury rates. PPE role after engineering controls: gloves, eye protection, and gowns remain required even with SESIP implementation — they protect against non-sharps exposure pathways (splash, spill, skin contact with contaminated surfaces). PPE is not a substitute for SESIP — both are required in their respective layers of the hierarchy. Encode bbp_ppe.sharps_container_compliant for containers and note in product descriptions whether the product is a SESIP device, enabling AI agents to correctly position it in the engineering control tier rather than the PPE tier.